
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur Daniel R. HANSON |
Documents disponibles écrits par cet auteur (2)



Biologically flavored perspectives on Garmezian resilience / Daniel R. HANSON in Development and Psychopathology, 24-2 (May 2012)
![]()
[article]
Titre : Biologically flavored perspectives on Garmezian resilience Type de document : Texte imprimé et/ou numérique Auteurs : Daniel R. HANSON, Auteur ; Irving I. GOTTESMAN, Auteur Année de publication : 2012 Article en page(s) : p.363-369 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Norman Garmezy devoted the better part of four decades developing and promoting the construct of resilience for developmental psychopathology. He proposed resilience as a paradigm to guide the understanding of how people can transcend adversity and go on to live healthy, productive lives. This tribute to Norman starts with a look at the early context for his work during his distinguished tenure in the Department of Psychology at the University of Minnesota. Resilience constructs are then compared from interdisciplinary perspectives across a variety of biological and physical sciences. All of these perspectives lead to similar conclusions: resilience is not a thing but a process. Furthermore, the processes are the product of energy-hungry systems. Finally, these insights are applied to difficult to modify maladaptive behaviors raising the question of a dark side to resilience. En ligne : http://dx.doi.org/10.1017/S0954579412000041 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=155
in Development and Psychopathology > 24-2 (May 2012) . - p.363-369[article] Biologically flavored perspectives on Garmezian resilience [Texte imprimé et/ou numérique] / Daniel R. HANSON, Auteur ; Irving I. GOTTESMAN, Auteur . - 2012 . - p.363-369.
Langues : Anglais (eng)
in Development and Psychopathology > 24-2 (May 2012) . - p.363-369
Index. décimale : PER Périodiques Résumé : Norman Garmezy devoted the better part of four decades developing and promoting the construct of resilience for developmental psychopathology. He proposed resilience as a paradigm to guide the understanding of how people can transcend adversity and go on to live healthy, productive lives. This tribute to Norman starts with a look at the early context for his work during his distinguished tenure in the Department of Psychology at the University of Minnesota. Resilience constructs are then compared from interdisciplinary perspectives across a variety of biological and physical sciences. All of these perspectives lead to similar conclusions: resilience is not a thing but a process. Furthermore, the processes are the product of energy-hungry systems. Finally, these insights are applied to difficult to modify maladaptive behaviors raising the question of a dark side to resilience. En ligne : http://dx.doi.org/10.1017/S0954579412000041 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=155 H. influenzae meningitis treated with ampicillin or chloramphenicol, and subsequent hearing loss / F. E. JONES in Developmental Medicine & Child Neurology, 19-5 (October 1977)
[article]
Titre : H. influenzae meningitis treated with ampicillin or chloramphenicol, and subsequent hearing loss Type de document : Texte imprimé et/ou numérique Auteurs : F. E. JONES, Auteur ; Daniel R. HANSON, Auteur Année de publication : 1977 Article en page(s) : p.593-597 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Sensori-neural hearing loss after H. influenzae meningitis in children has been reported to occur more frequently after treatment with ampicillin than with chloramphenicol. In the present survey, hearing was assessed clinically and, in most cases, audiometrically in 47 children seen after H. influenzae meningitis. Three children were found to have some sensori-neural hearing loss. In no case was this severe or suspected prior to examination. One was among 27 children treated with ampicillin; one was among eight treated with ampicillin and chloramphenicol; and one was treated with chloramphenicol and streptomycin. Most of the children received ampicillin in a dose of 250mg/kg/day or less, but the two who were treated with ampicillin and developed hearing loss were among five children who received higher doses, suggesting that ampicillin may be ototoxic when given in very high doses. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=467
in Developmental Medicine & Child Neurology > 19-5 (October 1977) . - p.593-597[article] H. influenzae meningitis treated with ampicillin or chloramphenicol, and subsequent hearing loss [Texte imprimé et/ou numérique] / F. E. JONES, Auteur ; Daniel R. HANSON, Auteur . - 1977 . - p.593-597.
Langues : Anglais (eng)
in Developmental Medicine & Child Neurology > 19-5 (October 1977) . - p.593-597
Index. décimale : PER Périodiques Résumé : Sensori-neural hearing loss after H. influenzae meningitis in children has been reported to occur more frequently after treatment with ampicillin than with chloramphenicol. In the present survey, hearing was assessed clinically and, in most cases, audiometrically in 47 children seen after H. influenzae meningitis. Three children were found to have some sensori-neural hearing loss. In no case was this severe or suspected prior to examination. One was among 27 children treated with ampicillin; one was among eight treated with ampicillin and chloramphenicol; and one was treated with chloramphenicol and streptomycin. Most of the children received ampicillin in a dose of 250mg/kg/day or less, but the two who were treated with ampicillin and developed hearing loss were among five children who received higher doses, suggesting that ampicillin may be ototoxic when given in very high doses. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=467